Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clin |
RCV001725188 | SCV001960885 | benign | Overgrowth syndrome and/or cerebral malformations due to abnormalities in MTOR pathway genes | 2022-02-11 | reviewed by expert panel | curation | The c.160G>A (NM_005027.4) variant in PIK3R2 is a missense variant predicted to cause substitution of (p.Val54Met). The highest population minor allele frequency in gnomAD v2.1.1 is 0.004092 in the European (non Finnish) population, which is higher than the ClinGen BMEP threshold ([>=0.00185]) for BA1, and therefore meets this criterion (BA1). In summary, this variant meets the criteria to be classified as Benign for mosaic autosomal dominant overgrowth with or without cerebral malformations due to abnormalities in MTOR-pathway genes based on the ACMG/AMP criteria applied, as specified by the ClinGen Brain Malformations Expert Panel: BA1; -8 points (VCEP specifications version 1; Approved: 1/31/2021) |
Labcorp Genetics |
RCV000551536 | SCV000644904 | benign | Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 1 | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001573664 | SCV001906910 | benign | not provided | 2018-10-30 | criteria provided, single submitter | clinical testing | |
Institute for Clinical Genetics, |
RCV001573664 | SCV002009741 | uncertain significance | not provided | 2021-11-03 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001573664 | SCV004145223 | likely benign | not provided | 2024-07-01 | criteria provided, single submitter | clinical testing | PIK3R2: BS2 |
Laboratory of Diagnostic Genome Analysis, |
RCV001573664 | SCV001799879 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV001700409 | SCV001923314 | benign | not specified | no assertion criteria provided | clinical testing | ||
Prevention |
RCV003935468 | SCV004753441 | benign | PIK3R2-related disorder | 2021-06-28 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |